FDA slaps China-based API makers with separate warning letters outlining quality, testing shortfalls
A pair of Chinese manufacturers with active pharmaceutical ingredients that were previously shipped to the U.S. | The FDA ...
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...
Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...
23—THURSDAY, Jan. 23, 2025 (HealthDay News) — The U.S. Food and Drug Administration has warned the pharmaceutical ... a warning letter was sent to Sanofi stating that FDA inspectors found ...
Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug your doctor prescribed.
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
French pharmaceutical giant Sanofi has received ... Biggest Boston biotech news coming out of JPM 2025 Hologic gets FDA warning regarding implantable devices Hologic gets FDA warning regarding ...
Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they said misleads patients about compounded weight ...
The health regulator is adding a new boxed warning, the FDA's most prominent warning ... is sold by Sandoz (SDZ.S), opens new tab. The companies did not immediately respond to requests for ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback